Hélène Merle-Béral Selected Research

Intraocular Lymphoma

1/2016	ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis.
1/2013	Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis.
5/2009	Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma.
7/2007	Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma.
7/2007	IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma.
2/2004	Biological diagnosis of primary intraocular lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hélène Merle-Béral Research Topics

Disease

16	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2019 - 07/2005
6	Neoplasms (Cancer) 10/2019 - 05/2011
6	Intraocular Lymphoma 01/2016 - 02/2004
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 07/2008
3	Lymphoma (Lymphomas) 01/2016 - 03/2008
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2011 - 05/2009
2	Leukemia 01/2019 - 11/2018
2	Residual Neoplasm 04/2017 - 06/2006
2	Cryoglobulinemia 03/2015 - 11/2004
2	Uveitis 01/2013 - 07/2007
2	B-Cell Lymphoma (Lymphoma, B Cell) 03/2008 - 07/2007
2	Genomic Instability 05/2006 - 06/2005
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Anemia 03/2015
1	Hypersensitivity (Allergy) 07/2014
1	Retinal Detachment (Retinal Detachments) 01/2013
1	Hemorrhage 01/2013
1	Disease Progression 07/2011
1	Vasculitis (Vasculitides) 12/2010
1	Purpura 12/2010
1	Lymphocytosis 11/2010
1	Carcinogenesis 07/2010
1	Genetic Translocation (Chromosomal Translocation) 07/2008
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2008
1	Liver Diseases (Liver Disease) 11/2004
1	Infections 11/2004
1	Trisomy (Trisomies) 10/2004
1	T-Cell Lymphoma (Lymphoma, T Cell) 02/2004
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2003

Drug/Important Bio-Agent (IBA)

4	Interleukin-10 (Interleukin 10)IBA 01/2016 - 02/2004
3	Peptides (Polypeptides)IBA 10/2019 - 03/2015
3	CaspasesIBA 01/2019 - 08/2003
3	InterleukinsIBA 01/2016 - 01/2013
3	Biological ProductsIBA 12/2010 - 02/2004
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 11/2018 - 07/2011
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 12/2010
2	CytokinesIBA 01/2013 - 07/2007
2	Messenger RNA (mRNA)IBA 05/2011 - 10/2007
2	CryoglobulinsIBA 12/2010 - 11/2004
2	DNA (Deoxyribonucleic Acid)IBA 07/2010 - 06/2005
2	Transcription Factors (Transcription Factor)IBA 07/2008 - 03/2008
2	Immunoglobulins (Immunoglobulin)IBA 01/2007 - 05/2006
1	CalciumIBA 01/2019
1	Phosphotransferases (Kinase)IBA 09/2015
1	Antiviral Agents (Antivirals)IBA 03/2015
1	Rheumatoid FactorIBA 03/2015
1	Oncogene Proteins (Oncogene Protein)IBA 07/2014
1	Immunoglobulin E (IgE)IBA 07/2014
1	InterferonsIBA 01/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013
1	N 30IBA 01/2013
1	Interleukin-4 (Interleukin 4)IBA 01/2013
1	Immunoglobulin M (IgM)IBA 07/2011
1	Tachykinin Receptors (Tachykinin Receptor)IBA 05/2011
1	TachykininsIBA 05/2011
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 05/2011
1	GlobulinsIBA 12/2010
1	Thymidine KinaseIBA 11/2010
1	Retinaldehyde (Retinal)IBA 05/2009
1	Fluorescein (Funduscein)FDA LinkGeneric 05/2009
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2009
1	PhosphatidylserinesIBA 04/2009
1	Serine Proteases (Serine Protease)IBA 04/2009
1	Actins (F Actin)IBA 04/2009
1	Protein Isoforms (Isoforms)IBA 03/2008
1	Rituximab (Mabthera)FDA Link 03/2008
1	LigandsIBA 09/2007
1	B-Cell Activating FactorIBA 09/2007
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2007
1	NucleotidesIBA 07/2006
1	Proteins (Proteins, Gene)FDA Link 07/2005
1	Indicators and Reagents (Reagents)IBA 07/2005
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 06/2005
1	MutagensIBA 10/2004
1	Cytochromes c (Cytochrome c)IBA 08/2003

Therapy/Procedure

3	Therapeutics 10/2015 - 04/2009
2	Stem Cell Transplantation 04/2017 - 06/2011
2	Ligation 07/2011 - 04/2009
1	Complementary Therapies (Alternative Medicine) 04/2009
1	Vitrectomy 07/2007
1	Aftercare (After-Treatment) 06/2006